Wall Street is positive on Genocea Biosciences Inc (GNCA). On average, analysts give the stock a Strong Buy rating. The average price target is $6.48, which means analysts expect the stock to climb by 109.03% over the next twelve months.
That average ranking earns the stock an Analyst Rating of 74, which is better than 74% of stocks based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With Genocea Biosciences Inc Stock Today?
Genocea Biosciences Inc (GNCA) stock is trading at $3.10 as of 2:15 PM on Tuesday, Feb 23, a drop of -$0.09, or -2.82% from the previous closing price of $3.19. The stock has traded between $2.78 and $3.25 so far today. Volume today is 689,171 compared to average volume of 844,720.
Click Here to get the full report on Genocea Biosciences Inc (GNCA) Stock.
